SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Williams KA, Emmerton LM, Taylor R, Werner J, Benrimoj SI. Int. J. Pharm. Pract. 2011; 19(3): 156-165.

Affiliation

Faculty of Pharmacy, The University of Sydney, Sydney; School of Pharmacy, The University of Queensland, Woolloongabba, Queensland; School of Public Health and Community Medicine, Faculty of Medicine, The University of New South Wales, Sydney, Australia.

Copyright

(Copyright © 2011, Royal Pharmaceutical Society of Great Britain, Publisher John Wiley and Sons)

DOI

10.1111/j.2042-7174.2010.00091.x

PMID

21554440

Abstract

Objective  To quantify pharmacy intervention rates for non-prescription medications (pharmacist-only and pharmacy medicines), to document the clinical significance of these interventions and to determine the adverse health consequences and subsequent health care avoided as a result of the interventions. Methods  Non-prescription medicines interventions undertaken by community pharmacy staff were recorded in two field studies: a study of all Australian pharmacies to determine incidence rates for low-incidence, highly significant interventions, and a study of a sample of pharmacies to collect data on all non-prescription interventions. Recorded interventions were assessed by a clinical panel for clinical significance, potential adverse health consequence avoided, probability and likely duration of the adverse health consequence. Key findings  The rate of professional intervention that occurs in Australia for pharmacist-only and pharmacy medicines is 5.66 per 1000 unit sales (95% confidence interval 4.79-6.64). Rates of intervention varied by clinical significance. When considering health care avoided, the main impact of the interventions was avoidance of urgent general practitioner (GP) visits, followed by avoidance of regular GP visits and accident and emergency treatment. The most common adverse health consequences avoided were exacerbations of an existing condition (e.g. hypertension, asthma) and adverse drug effects. Conclusions  This study demonstrates the way in which community pharmacy encourages appropriate non-prescription medicine use and prevents harm through intervening at the point of supply. It was estimated that Australian pharmacies perform 485 912 interventions per annum when dealing with non-prescription medicines, with 101 324 per annum being interventions that avert emergency medical attention or serious harm, or which are potentially life saving.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print